Nikkei 225 to temporarily include Resonac spinoff Crasus Chemical
We haven't written up this one. Nikkei Asia has the full story — the link below goes straight to it.
More in Finance & Markets
Yen Rally Gaining Further Momentum: 3-Minutes MLIV
Guy Johnson, Tom Mackenzie and Adam Linton break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade." (Source: Bloomberg)
Pharma major Novartis plummets 10%, heading for worst day on record after three drug trial setbacks
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
Why the Dow is being dragged down by a Swiss company’s bad news
Futures on the Dow were significantly worse than the S&P 500 because of a cardiovascular drug’s late-stage setback.
Why the Dow is being dragged down by a Swiss company’s bad news
Futures on the Dow were significantly worse than the S&P 500 because of a cardiovascular drug’s late-stage setback.
QPE’s Initiate completes add-on acquisition of Dark Peak Analytics
The specialist health economics modeling and analytics business joins Initiate's market access and HEOR platform. The post QPE’s Initiate completes add-on acquisition of Dark Peak Analytics appeared…